# AEL03 listing is produced correctly

    Code
      result
    Output
      Listing of Serious Adverse Events
      
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
                                                                                                Date of                                                                                    Reason  
                                                                               Adverse        First Study     Study       AE        Most      Caused by                         Action   Classified
                                                                             Event MedDRA         Drug        Day of   Duration    Extreme      Study     Outcome   Treatment   Taken    as Serious
      Center/Patient ID            Age/Sex/Race              Treatment      Preferred Term   Administration   Onset    in Days    Intensity     Drug        (1)      for AE      (2)        (3)    
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      BRA-1/id-134        47/M/WHITE                       A: Drug X        dcd A.1.1.1.2    04NOV2020        321      149        MODERATE    No          5         Yes         2        4         
                                                                            dcd A.1.1.1.2    04NOV2020        393      43         MODERATE    No          5         No          5        5         
      BRA-1/id-141        35/F/WHITE                       C: Combination   dcd A.1.1.1.2    25JUL2020        899      139        MODERATE    No          4         Yes         2        4         
                                                                            dcd D.1.1.1.1    25JUL2020        1093     3          SEVERE      Yes         1         No          6        1         
      BRA-1/id-236        32/M/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd B.1.1.1.1    15JAN2021        33       614        SEVERE      Yes         1         No          6        1         
                                                                            dcd B.1.1.1.1    15JAN2021        271      775        SEVERE      Yes         1         Yes         6        1         
                                                                            dcd B.1.1.1.1    15JAN2021        1051     7          SEVERE      Yes         1         Yes         6        1         
      BRA-1/id-265        25/M/WHITE                       C: Combination   dcd D.1.1.1.1    07OCT2019        685      37         SEVERE      Yes         1         No          6        1         
      BRA-1/id-42         36/M/BLACK OR AFRICAN AMERICAN   A: Drug X        dcd D.1.1.1.1    01JAN2020        64       630        SEVERE      Yes         1         No          6        1         
                                                                            dcd A.1.1.1.2    01JAN2020        160      259        MODERATE    No          2         Yes         2        4         
                                                                            dcd B.2.2.3.1    01JAN2020        292      50         MILD        No          3         No          2        4         
                                                                            dcd A.1.1.1.2    01JAN2020        459      195        MODERATE    No          5         Yes         2        5         
                                                                            dcd B.1.1.1.1    01JAN2020        470      131        SEVERE      Yes         1         No          6        1         
                                                                            dcd A.1.1.1.2    01JAN2020        475      113        MODERATE    No          4         Yes         2        4         
                                                                            dcd B.1.1.1.1    01JAN2020        641      15         SEVERE      Yes         1         Yes         6        1         
      BRA-1/id-65         25/F/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd B.1.1.1.1    15JUL2019        349      441        SEVERE      Yes         1         No          6        1         
      BRA-1/id-93         34/F/ASIAN                       A: Drug X        dcd D.1.1.1.1    20JUN2020        316      250        SEVERE      Yes         1         No          6        1         
                                                                            dcd B.1.1.1.1    20JUN2020        523      24         SEVERE      Yes         1         No          6        1         
                                                                            dcd B.2.2.3.1    20JUN2020        596      10         MILD        No          3         Yes         2        4         
      BRA-11/id-321       33/F/ASIAN                       C: Combination   dcd A.1.1.1.2    06OCT2020        427      335        MODERATE    No          4         No          6        2         
                                                                            dcd B.1.1.1.1    06OCT2020        892      58         SEVERE      Yes         1         Yes         6        1         
      BRA-11/id-345       37/F/WHITE                       A: Drug X        dcd B.1.1.1.1    18AUG2020        1009     35         SEVERE      Yes         1         No          6        1         
      BRA-11/id-397       38/M/ASIAN                       A: Drug X        dcd D.1.1.1.1    27JUN2020        516      441        SEVERE      Yes         1         No          6        1         
                                                                            dcd B.1.1.1.1    27JUN2020        1011     30         SEVERE      Yes         1         Yes         6        1         
      BRA-11/id-50        26/M/BLACK OR AFRICAN AMERICAN   A: Drug X        dcd A.1.1.1.2    28APR2019        1007     68         MODERATE    No          3         Yes         2        5         
      BRA-11/id-9         40/M/ASIAN                       C: Combination   dcd B.2.2.3.1    25MAR2019        441      53         MILD        No          5         No          2        3         
                                                                            dcd D.1.1.1.1    25MAR2019        445      598        SEVERE      Yes         1         No          6        1         
                                                                            dcd B.1.1.1.1    25MAR2019        644      42         SEVERE      Yes         1         No          6        1         
                                                                            dcd B.2.2.3.1    25MAR2019        669      100        MILD        No          5         Yes         2        3         
      BRA-12/id-59        36/M/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd D.1.1.1.1    25NOV2019        9        232        SEVERE      Yes         1         Yes         6        1         
                                                                            dcd B.2.2.3.1    25NOV2019        229      160        MILD        No          3         No          2        3         
      BRA-13/id-177       24/M/WHITE                       A: Drug X        dcd B.1.1.1.1    30AUG2020        249      470        SEVERE      Yes         1         No          6        1         
                                                                            dcd B.1.1.1.1    30AUG2020        1012     33         SEVERE      Yes         1         No          6        1         
      BRA-14/id-120       33/F/ASIAN                       C: Combination   dcd A.1.1.1.2    19SEP2020        4        245        MODERATE    No          2         No          5        6         
                                                                            dcd A.1.1.1.2    19SEP2020        74       393        MODERATE    No          6         No          2        6         
                                                                            dcd A.1.1.1.2    19SEP2020        92       329        MODERATE    No          6         No          2        3         
                                                                            dcd A.1.1.1.2    19SEP2020        208      189        MODERATE    No          5         No          3        4         
                                                                            dcd A.1.1.1.2    19SEP2020        251      142        MODERATE    No          3         No          5        4         
                                                                            dcd B.2.2.3.1    19SEP2020        504      7          MILD        No          4         No          7        6         
      BRA-15/id-36        38/F/ASIAN                       A: Drug X        dcd B.1.1.1.1    08JAN2020        372      154        SEVERE      Yes         1         Yes         6        1         
                                                                            dcd A.1.1.1.2    08JAN2020        573      134        MODERATE    No          3         Yes         2        3         
      BRA-2/id-101        34/M/ASIAN                       B: Placebo       dcd A.1.1.1.2    26JUN2020        650      300        MODERATE    No          5         Yes         2        4         
      BRA-2/id-296        44/F/ASIAN                       A: Drug X        dcd A.1.1.1.2    22JAN2021        204      487        MODERATE    No          5         Yes         2        4         
                                                                            dcd A.1.1.1.2    22JAN2021        289      259        MODERATE    No          2         Yes         2        3         
                                                                            dcd B.1.1.1.1    22JAN2021        1042     53         SEVERE      Yes         1         No          6        1         
      BRA-3/id-8          25/F/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd A.1.1.1.2    12MAR2020        48       98         MODERATE    No          3         Yes         3        4         
      BRA-4/id-368        46/M/BLACK OR AFRICAN AMERICAN   C: Combination   dcd D.1.1.1.1    25FEB2020        836      114        SEVERE      Yes         1         No          6        1         
                                                                            dcd B.1.1.1.1    25FEB2020        841      247        SEVERE      Yes         1         No          6        1         
      BRA-4/id-383        30/F/ASIAN                       B: Placebo       dcd A.1.1.1.2    18JAN2020        253      211        MODERATE    No          2         No          6        5         
                                                                            dcd A.1.1.1.2    18JAN2020        286      191        MODERATE    No          4         Yes         7        3         
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      
      (1) Outcome: 1 = fatal; 2 = not recovered/not resolved; 3 = recovered/resolved;
          4 = recovered/resolved with sequelae; 5 = recovering/resolving; 6 = unknown.
      (2) Action taken with study drug: 1 = dose increased; 2 = dose not changed; 3 = dose reduced; 4 = drug interrupted;
          5 = drug withdrawn; 6 = not applicable; 7 = unknown.
      (3) Reason classified as serious: 1 = resulted in death; 2 = life threatening; 3 = required prolonged in patient
          hospitalization; 4 = disabling; 5 = a congenital anomaly/birth defect in offspring of study subject;
          6 = does not meet any of the above serious criteria, but may jeopardize the subject, and may require medical or
          surgical intervention to prevent one of the outcomes listed above.
      *  Study day derived from imputed onset date.
      ** Duration derived from imputed onset date and/or end date.

